465. Use of Monoclonal Antibodies for COVID-19 in Solid Organ Transplant Recipients: A Single-Center Experience

BACKGROUND: The use of coronavirus disease 2019 (COVID-19) monoclonal antibody (mAb) treatment in solid organ transplant (SOT) patients have been shown to reduce the rates of hospitalization, Emergency Department (ED) visits, and mortality in previous studies. However, most of these studies provide...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez, Keven, Arcobello, Jonathan T, Chang, Sandy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678004/
http://dx.doi.org/10.1093/ofid/ofad500.535

Ejemplares similares

Ejemplares similares